F-group (family)
2498.1.1.4 Reprolysin
Ligands and drugs
489
Member domains
111
with ligand contacts (≤ 4 Å)
22.7% of members
90
with DrugDomain annotations
18.4% of members
43
with a DrugBank compound
8.8% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 2498.1.1.4 belongs to X-group 2498 Zincin-like, which binds 9.5 ligand superclasses per 20 proteins, broader than 89% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB02255 | GM6 | Ilomastat | 8 |
| DB03880 | BAT | Batimastat | 8 |
| DB00141 | NAG | N-Acetylglucosamine | 7 |
| DB00786 | 097 | Marimastat | 5 |
| DB08733 | WR2 | (2R,3R)-N^1^-[(1S)-2,2-DIMETHYL-1-(METHYLCARBAMOYL)PROPYL]-N^4^-HYDROXY-2-(2-METHYLPROPYL)-3-{[(1,3-THIAZOL-2-YLCARBONYL)AMINO]METHYL}BUTANEDIAMIDE | 5 |
| DB02046 | FLX | N-[(Furan-2-Yl)Carbonyl]-(S)-Leucyl-(R)-[1-Amino-2(1h-Indol-3-Yl)Ethyl]-Phosphonic Acid | 2 |
| DB02215 | FLE | Furoyl-Leucine | 2 |
| DB06837 | 099 | (2R)-N~4~-hydroxy-2-(3-hydroxybenzyl)-N~1~-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]butanediamide | 2 |
| DB06945 | 294 | N-hydroxy-4-({4-[4-(trifluoromethyl)phenoxy]phenyl}sulfonyl)tetrahydro-2H-pyran-4-carboxamide | 2 |
| DB18824 | OU5 | Aldumastat | 2 |
| DB00150 | TRP | Tryptophan | 1 |
| DB02996 | — | — | 1 |
| DB03088 | — | Pidolic acid | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| ZNmetal | ZINC ION | 86 |
| CAmetal | CALCIUM ION | 83 |
| NAG | 2-acetamido-2-deoxy-beta-D-glucopyranose | 17 |
| CDmetal | CADMIUM ION | 12 |
| NAmetal | SODIUM ION | 11 |
| CL | CHLORIDE ION | 8 |
| NImetal | NICKEL (II) ION | 8 |
| BAT | 4-(N-HYDROXYAMINO)-2R-ISOBUTYL-2S-(2-THIENYLTHIOMETHYL)SUCCINYL-L-PHENYLALANINE-N-METHYLAMIDE | 7 |
| GM6 | 3-(N-HYDROXYCARBOXAMIDO)-2-ISOBUTYLPROPANOYL-TRP-METHYLAMIDE | 7 |
| MGmetal | MAGNESIUM ION | 7 |
| 097 | (2S,3R)-N~4~-[(1S)-2,2-dimethyl-1-(methylcarbamoyl)propyl]-N~1~,2-dihydroxy-3-(2-methylpropyl)butanediamide | 5 |
| 886 | N-({4'-[(4-isobutyrylphenoxy)methyl]biphenyl-4-yl}sulfonyl)-D-valine | 4 |
| WR2 | (2R,3R)-N^1^-[(1S)-2,2-DIMETHYL-1-(METHYLCARBAMOYL)PROPYL]-N^4^-HYDROXY-2-(2-METHYLPROPYL)-3-{[(1,3-THIAZOL-2-YLCARBONYL)AMINO]METHYL}BUTANEDIAMIDE | 4 |
| 098 | (3R)-N~2~-(cyclopropylmethyl)-N~1~-hydroxy-3-(3-hydroxybenzyl)-N~4~-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]-L-aspartamide | 2 |
| 099 | (2R)-N~4~-hydroxy-2-(3-hydroxybenzyl)-N~1~-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]butanediamide | 2 |
| 0QI | O-methyl-N-[(2S)-4-methyl-2-(sulfanylmethyl)pentanoyl]-L-tyrosine | 2 |
| 294 | N-hydroxy-4-({4-[4-(trifluoromethyl)phenoxy]phenyl}sulfonyl)tetrahydro-2H-pyran-4-carboxamide | 2 |
| 3COmetal | COBALT (III) ION | 2 |
| FLE | FUROYL-LEUCINE | 2 |
| OU5 | (5~{S})-5-[3-[(3~{S})-4-[3,5-bis(fluoranyl)phenyl]-3-methyl-piperazin-1-yl]-3-oxidanylidene-propyl]-5-cyclopropyl-imidazolidine-2,4-dione | 2 |